The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Frequency of comedication of proton pump inhibitors with crystalline dasatinib in chronic myeloid leukemia and effects on TKI-bioavailability.
 
Torsten Dahlén
Consulting or Advisory Role - XSpray Microparticles AB
Research Funding - Novartis (Inst)
 
Gunnar Larfors
Consulting or Advisory Role - XSpray Microparticles AB
 
Hans Lennernäs
Stock and Other Ownership Interests - AstraZeneca; Lidds; Medivir Nanologica; Novo Nordisk; XSpray Microparticles AB
Consulting or Advisory Role - Vicore; XSpray Microparticles AB
Research Funding - AstraZeneca; Vicor
 
Charlotta Liljebris
Employment - XSpray Microparticles AB
Leadership - XSpray Microparticles AB
Stock and Other Ownership Interests - XSpray Microparticles AB
 
Mikael Von Euler
Leadership - Annexin Therapeutics AB; Dicot AB
Stock and Other Ownership Interests - Dicot AB; Targovax; XSpray Microparticles AB
Consulting or Advisory Role - Herantis Ltd; MyCural Therapeutics AB; Oxcia AB; Valo Therpeutics; Vivesto AB; XSpray Microparticles AB
 
Magnus Brisander
Stock and Other Ownership Interests - XSpray Microparticles AB
Consulting or Advisory Role - Xsrpay
Patents, Royalties, Other Intellectual Property - XSpray Microparticles AB
 
Per Andersson
Employment - Xsrpay
Leadership - Xsrpay
Stock and Other Ownership Interests - XSpray Microparticles AB
 
Leif Stenke
Consulting or Advisory Role - XSpray Microparticles AB